{
  "ticker": "GILD",
  "company_name": "Gilead Sciences, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT02309918",
      "title": "HepNet Acute HCV IV - LDV/SOF FDC in Acute Genotype 1 Hepatitis C Virus Infection",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Acute Hepatitis C",
      "start_date": "2014-11",
      "completion_date": "2016-08",
      "enrollment": 0,
      "sponsor": "HepNet Study House, German Liverfoundation"
    },
    {
      "nct_id": "NCT02652624",
      "title": "Safety and Efficacy of Switching to a FDC of B/F/TAF From E/C/F/TAF, E/C/F/TDF, or ATV+RTV+FTC/TDF in Virologically Suppressed HIV-1 Infected Women",
      "status": "COMPLETED",
      "phase": "PHASE3",
      "condition": "HIV-1 Infection",
      "start_date": "2016-02-19",
      "completion_date": "2018-11-26",
      "enrollment": 0,
      "sponsor": "Gilead Sciences"
    },
    {
      "nct_id": "NCT01369498",
      "title": "Efficacy and Safety of Simtuzumab in Adults With Primary, Post Polycythemia Vera or Post Essential Thrombocythemia Myelofibrosis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Myelofibrosis",
      "start_date": "2011-06-30",
      "completion_date": "2014-09-24",
      "enrollment": 0,
      "sponsor": "Gilead Sciences"
    },
    {
      "nct_id": "NCT07001319",
      "title": "Study of GS-3242 in Participants With HIV-1; Substudy-05",
      "status": "RECRUITING",
      "phase": "PHASE1",
      "condition": "HIV-1-infection",
      "start_date": "2025-05-29",
      "completion_date": "2027-02",
      "enrollment": 0,
      "sponsor": "Gilead Sciences"
    },
    {
      "nct_id": "NCT01671787",
      "title": "A Phase 1b Study Assessing GS-7340 in Treatment-Naive Adults With Chronic Hepatitis B",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Chronic Hepatitis B",
      "start_date": "2012-03",
      "completion_date": "2013-04",
      "enrollment": 0,
      "sponsor": "Gilead Sciences"
    },
    {
      "nct_id": "NCT03987074",
      "title": "Safety, Tolerability, and Efficacy of Monotherapy and Combination Regimens in Participants With Nonalcoholic Steatohepatitis (NASH)",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Nonalcoholic Steatohepatitis",
      "start_date": "2019-07-29",
      "completion_date": "2020-07-13",
      "enrollment": 0,
      "sponsor": "Gilead Sciences"
    },
    {
      "nct_id": "NCT00528060",
      "title": "Measure of Pharmacokinetic Parameters and Adherence With MEMS in Naive HIV Infected Patients Treated With Reyataz Once Daily Combined With Norvir and Truvada",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "HIV Infections",
      "start_date": "2008-01",
      "completion_date": "2008-11",
      "enrollment": 0,
      "sponsor": "French National Agency for Research on AIDS and Viral Hepatitis"
    },
    {
      "nct_id": "NCT01849003",
      "title": "Study of the Effect of GS-6615 in Subjects With LQT-3",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Long QT Syndrome",
      "start_date": "2013-05",
      "completion_date": "2014-11",
      "enrollment": 0,
      "sponsor": "Gilead Sciences"
    },
    {
      "nct_id": "NCT07163481",
      "title": "A Trial to Evaluate Sacituzumab Govitecan in Combination With Endocrine Therapy in Patients With HR-positive, HER2-negative Metastatic Breast Cancer Progressed on CDK4/6 Inhibitors",
      "status": "NOT_YET_RECRUITING",
      "phase": "PHASE1",
      "condition": "Stage IV (Metastatic) Breast Cancer",
      "start_date": "2025-10",
      "completion_date": "2026-12",
      "enrollment": 0,
      "sponsor": "Hunan Cancer Hospital"
    },
    {
      "nct_id": "NCT03890120",
      "title": "Study of Cilofexor in Adults With Primary Sclerosing Cholangitis",
      "status": "TERMINATED",
      "phase": "PHASE3",
      "condition": "Primary Sclerosing Cholangitis",
      "start_date": "2019-03-27",
      "completion_date": "2022-12-23",
      "enrollment": 0,
      "sponsor": "Gilead Sciences"
    }
  ],
  "summary": {
    "total_trials": 50,
    "by_phase": {
      "PHASE2": 8,
      "PHASE3": 12,
      "PHASE1": 9,
      "NA": 3,
      "": 9,
      "PHASE2, PHASE3": 1,
      "PHASE4": 4,
      "PHASE1, PHASE2": 3,
      "EARLY_PHASE1": 1
    },
    "by_status": {
      "COMPLETED": 31,
      "RECRUITING": 2,
      "NOT_YET_RECRUITING": 1,
      "TERMINATED": 7,
      "APPROVED_FOR_MARKETING": 2,
      "ACTIVE_NOT_RECRUITING": 4,
      "AVAILABLE": 1,
      "UNKNOWN": 2
    },
    "active_trials": 6,
    "completed_trials": 31,
    "conditions": [
      "Absence of Signs or Symptoms, B-Cell Non-Hodgkin Lymphoma, Digestive System Signs and Symptoms, Indolent Adult Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma, Recurrent Chronic Lymphocytic Leukemia, Recurrent Indolent Adult Non-Hodgkin Lymphoma, Recurrent Small Lymphocytic Lymphoma",
      "Acute Hepatitis C",
      "Allergic Rhinitis",
      "Arrhythmia",
      "COVID-19",
      "Chronic HCV Infection",
      "Chronic Hepatitis B",
      "Chronic Hepatitis C Virus",
      "Chronic Hepatitis D Infection With Hepatitis B",
      "Chronic Hepatitis Delta Virus Infection",
      "Chronic Lymphocytic Leukemia (CLL)",
      "Chronic Stable Angina",
      "Cystic Fibrosis, Pseudomonas Aeruginosa Airway Infection",
      "Diabetic Peripheral Neuropathic Pain",
      "Follicular Lymphoma",
      "Fungemia",
      "Glioblastoma",
      "HER2 Negative Breast Carcinoma Expressing CEA",
      "HIV",
      "HIV Infections",
      "HIV-1 Infection",
      "HIV-1-Infection",
      "HIV-1-infection",
      "Hepatitis B",
      "Hepatitis B, Liver Cirrhosis, Carcinoma, Hepatocellular",
      "Hepatitis C",
      "Hepatitis C Virus Infection",
      "Hepatitis C, Severe Mental Disorder",
      "Hiv, Substance Use Disorders",
      "Invasive Fungal Infections",
      "Long QT Syndrome",
      "Myelofibrosis",
      "Non-Small Cell Lung Cancer",
      "Non-hodgkin's Lymphoma, Follicular Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma, Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma",
      "Nonalcoholic Steatohepatitis",
      "Osteoporosis, HIV, Menopause",
      "Ovarian Cancer",
      "Primary Sclerosing Cholangitis",
      "Pseudomonas Aeruginosa Respiratory Tract Infection/Colonization, Cystic Fibrosis",
      "Pulmonary Arterial Hypertension",
      "Solid Tumor",
      "Solid Tumor, Colorectal Cancer",
      "Solid Tumor, Unspecified, Adult",
      "Stage IV (Metastatic) Breast Cancer"
    ],
    "lead_stage": "commercial"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:18:37.057532",
    "search_query": "Gilead Sciences, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Gilead+Sciences,+Inc."
  }
}